The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions
Sign Up to like & getrecommendations! Published in 2021 at "Immunopharmacology and Immunotoxicology"
DOI: 10.1080/08923973.2021.1954946
Abstract: Abstract Background Nonalcoholic Steatohepatitis (NASH) results from the accumulation of fatty acids in the liver. The elevated production of pro-inflammatory factors is the reason for the hyper inflammation in NASH. The α-L-Guluronic acid (G2013), a… read more here.
Keywords: secretion; acid g2013; nonalcoholic steatohepatitis; guluronic acid ... See more keywords
The Open, Randomized, Positive Control Clinical Trial of Guluronic Acid (G2013) on SARS-CoV-2 Patients.
Sign Up to like & getrecommendations! Published in 2023 at "Current drug discovery technologies"
DOI: 10.2174/1570163820666230418095115
Abstract: INTRODUCTION Recently, the coronavirus disease 2019 (COVID-19) infection, with a vast spectrum of clinical and paraclinical symptoms has been a major health concern worldwide. Therapeutical management of COVID-19 includes antiviral and anti-inflammatory drugs. NSAIDs, as… read more here.
Keywords: guluronic acid; control; acid g2013; covid ... See more keywords